Skip to main content
NCBI home page
CMAJ : Canadian Medical Association Journal logoLink to CMAJ : Canadian Medical Association Journal
. 1986 May 15;134(10):1141–1147.

Clinical applications of assays for thyrotropin-receptor antibodies in Graves' disease.

J Ginsberg, C von Westarp
PMCID: PMC1491069  PMID: 2421862

Abstract

Graves' disease is characterized by hyperthyroidism, diffuse goitre, infiltrative ophthalmopathy and, rarely, pretibial myxedema. In 1956 a substance capable of prolonged thyroid stimulation was discovered in the serum of some patients with Graves' disease and termed long-acting thyroid stimulator (LATS). It was shown to be an antibody that could interact with the receptor for thyroid-stimulating hormone (TSH). The term LATS is usually reserved for the activity measured in a laborious in-vivo bioassay in mice. Today the activity of TSH-receptor antibodies (TSH-R Ab) can be measured by in-vitro bioassays or by radioreceptor assays. These assays are now becoming commercially available. TSH-R Ab assays may be useful in predicting the response to therapy for Graves' disease, investigating euthyroid ophthalmopathy and predicting the likelihood of neonatal hyperthyroidism.

Full text

PDF
1141

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Adams D. D., Kennedy T. H. Occurrence in thyrotoxicosis of a gamma globulin which protects LATS from neutralization by an extract of thyroid gland. J Clin Endocrinol Metab. 1967 Feb;27(2):173–177. doi: 10.1210/jcem-27-2-173. [DOI] [PubMed] [Google Scholar]
  2. Atkinson S., Kendall-Taylor P. The stimulation of thyroid hormone secretion in vitro by thyroid-stimulating antibodies. J Clin Endocrinol Metab. 1981 Dec;53(6):1263–1266. doi: 10.1210/jcem-53-6-1263. [DOI] [PubMed] [Google Scholar]
  3. Baker J. R., Jr, Lukes Y. G., Burman K. D. Production, isolation, and characterization of rabbit anti-idiotypic antibodies directed against human antithyrotrophin receptor antibodies. J Clin Invest. 1984 Aug;74(2):488–495. doi: 10.1172/JCI111446. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. Baker J. R., Jr, Lukes Y. G., Smallridge R. C., Berger M., Burman K. D. Partial characterization and clinical correlation of circulating human immunoglobulins directed against thyrotrophin binding sites in guinea pig fat cell membranes. Development of a direct enzyme immunoassay. J Clin Invest. 1983 Oct;72(4):1487–1497. doi: 10.1172/JCI111105. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. Baxter J. D., Funder J. W. Hormone receptors. N Engl J Med. 1979 Nov 22;301(21):1149–1161. doi: 10.1056/NEJM197911223012104. [DOI] [PubMed] [Google Scholar]
  6. Bech K., Nistrup Madsen S. Thyroid adenylate cyclase stimulating immunoglobulins in thyroid diseases. Clin Endocrinol (Oxf) 1979 Jul;11(1):47–58. doi: 10.1111/j.1365-2265.1979.tb03045.x. [DOI] [PubMed] [Google Scholar]
  7. Bitensky L., Alaghband-Zadeh J., Chayen J. Studies on thyroid stimulating hormone and the long-acting thyroid stimulating hormone. Clin Endocrinol (Oxf) 1974 Jul;3(3):363–374. doi: 10.1111/j.1365-2265.1974.tb01811.x. [DOI] [PubMed] [Google Scholar]
  8. Bliddal H., Kirkegaard C., Siersbaek-Nielsen K., Friis T. Prognostic value of thyrotrophin binding inhibiting immunoglobulins (TBII) in longterm antithyroid treatment, 131I therapy given in combination with carbimazole and in euthyroid ophthalmopathy. Acta Endocrinol (Copenh) 1981 Nov;98(3):364–369. doi: 10.1530/acta.0.0980364. [DOI] [PubMed] [Google Scholar]
  9. Borges M., Ingbar J. C., Endo K., Amir S., Uchimura H., Nagataki S., Ingbar S. H. A new method for assessing the thyrotropin binding inhibitory activity in the immunoglobulins and whole serum of patients with Graves' disease. J Clin Endocrinol Metab. 1982 Mar;54(3):552–558. doi: 10.1210/jcem-54-3-552. [DOI] [PubMed] [Google Scholar]
  10. Cove D. H., Johnston P. Fetal hyperthyroidism: experience of treatment in four siblings. Lancet. 1985 Feb 23;1(8426):430–432. doi: 10.1016/s0140-6736(85)91148-1. [DOI] [PubMed] [Google Scholar]
  11. Davies T. F. Autoantibodies to the human thyrotropin receptor are not species specific. J Clin Endocrinol Metab. 1981 Mar;52(3):426–430. doi: 10.1210/jcem-52-3-426. [DOI] [PubMed] [Google Scholar]
  12. Davies T. F., Platzer M., Farid N. R. Prediction of therapeutic response to radioactive iodine in Graves' disease using TSH-receptor antibodies and HLA-status. Clin Endocrinol (Oxf) 1982 Feb;16(2):183–191. doi: 10.1111/j.1365-2265.1982.tb03163.x. [DOI] [PubMed] [Google Scholar]
  13. Davies T. F., Teng C. S., McLachlan S. M., Smith B. R., Hall R. Thyrotropin receptors in adipose tissue, retro-orbital tissue and lymphocytes. Mol Cell Endocrinol. 1978 Jan;9(3):303–310. doi: 10.1016/0303-7207(78)90072-2. [DOI] [PubMed] [Google Scholar]
  14. Davies T. F., Yeo P. P., Evered D. C., Clark F., Smith B. R., Hall R. Value of thyroid-stimulating-antibody determinations in predicting short-term thyrotoxic relapse in Graves' disease. Lancet. 1977 Jun 4;1(8023):1181–1182. doi: 10.1016/s0140-6736(77)92719-2. [DOI] [PubMed] [Google Scholar]
  15. Drexhage H. A., Bottazzo G. F., Bitensky L., Chayen J., Doniach D. Thyroid growth-blocking antibodies in primary myxoedema. Nature. 1981 Feb 12;289(5798):594–596. doi: 10.1038/289594a0. [DOI] [PubMed] [Google Scholar]
  16. Endo K., Amir S. M., Ingbar S. H. Development and evaluation of a method for the partial purification of immunoglobulins specific for Graves' disease. J Clin Endocrinol Metab. 1981 Jun;52(6):1113–1123. doi: 10.1210/jcem-52-6-1113. [DOI] [PubMed] [Google Scholar]
  17. Endo K., Kasagi K., Konishi J., Ikekubo K., Okuno T., Takeda Y., Mori T., Torizuka K. Detection and properties of TSH-binding inhibitor immunoglobulins in patients with Graves' disease and Hashimoto's thyroiditis. J Clin Endocrinol Metab. 1978 May;46(5):734–739. doi: 10.1210/jcem-46-5-734. [DOI] [PubMed] [Google Scholar]
  18. Fenzi G., Hashizume K., Roudebush C. P., DeGroot L. J. Changes in thyroid-stimulating immunoglobulins during antithyroid therapy. J Clin Endocrinol Metab. 1979 Apr;48(4):572–576. doi: 10.1210/jcem-48-4-572. [DOI] [PubMed] [Google Scholar]
  19. Ginsberg J., Shewring G., Howells R., Smith B. R., Hall R. Stimulation of iodine organification in porcine thyroid cells by thyroid stimulators. Life Sci. 1983 Jan 3;32(1-2):153–160. doi: 10.1016/0024-3205(83)90182-0. [DOI] [PubMed] [Google Scholar]
  20. Ginsberg J., Shewring G., Smith B. R. TSH receptor binding and thyroid stimulation by sera from patients with Graves' disease. Clin Endocrinol (Oxf) 1983 Sep;19(3):305–311. doi: 10.1111/j.1365-2265.1983.tb00003.x. [DOI] [PubMed] [Google Scholar]
  21. Hollingsworth D. R., Mabry C. C. Congenital graves disease. Four familial cases with long-term follow-up and perspective. Am J Dis Child. 1976 Feb;130(2):148–155. doi: 10.1001/archpedi.1976.02120030038008. [DOI] [PubMed] [Google Scholar]
  22. Kasagi K., Konishi J., Iida Y., Ikekubo K., Mori T., Kuma K., Torizuka K. A new in vitro assay for human thyroid stimulator using cultured thyroid cells: effect of sodium chloride on adenosine 3',5'-monophosphate increase. J Clin Endocrinol Metab. 1982 Jan;54(1):108–114. doi: 10.1210/jcem-54-1-108. [DOI] [PubMed] [Google Scholar]
  23. Kendall-Taylor P. Adenyl cyclase activity in the mouse thyroid gland. J Endocrinol. 1972 Mar;52(3):533–540. doi: 10.1677/joe.0.0520533. [DOI] [PubMed] [Google Scholar]
  24. Manley S. W., Bourke J. R., Hawker R. W. The thyrotrophin receptor in guinea-pig thyroid homogenate: interaction with the long-acting thyroid stimulator. J Endocrinol. 1974 Jun;61(3):437–445. doi: 10.1677/joe.0.0610437. [DOI] [PubMed] [Google Scholar]
  25. Matsuura N., Yamada Y., Nohara Y., Konishi J., Kasagi K., Endo K., Kojima H., Wataya K. Familial neonatal transient hypothyroidism due to maternal TSH-binding inhibitor immunoglobulins. N Engl J Med. 1980 Sep 25;303(13):738–741. doi: 10.1056/NEJM198009253031306. [DOI] [PubMed] [Google Scholar]
  26. McGregor A. M., Petersen M. M., McLachlan S. M., Rooke P., Smith B. R., Hall R. Carbimazole and the autoimmune response in Graves' disease. N Engl J Med. 1980 Aug 7;303(6):302–307. doi: 10.1056/NEJM198008073030603. [DOI] [PubMed] [Google Scholar]
  27. McGregor A. M., Smith B. R., Hall R., Petersen M. M., Miller M., Dewar P. J. Prediction of relapse in hyperthyroid Graves' disease. Lancet. 1980 May 24;1(8178):1101–1103. doi: 10.1016/s0140-6736(80)91551-2. [DOI] [PubMed] [Google Scholar]
  28. McKENZIE J. M. The bioassay of thyrotropin in serum. Endocrinology. 1958 Sep;63(3):372–382. doi: 10.1210/endo-63-3-372. [DOI] [PubMed] [Google Scholar]
  29. McKenzie J. M., Zakarija M. Pathogenesis of neonatal Graves' disease. J Endocrinol Invest. 1978 Apr;1(2):183–189. doi: 10.1007/BF03350370. [DOI] [PubMed] [Google Scholar]
  30. Mehdi S. Q., Nussey S. S. A radio-ligand receptor assay for the long-acting thyroid stimulator. Inhibition by the long-acting thyroid stimulator of the binding of radioiodinated thyroid-stimulating hormone to human thyroid membranes. Biochem J. 1975 Jan;145(1):105–111. doi: 10.1042/bj1450105. [DOI] [PMC free article] [PubMed] [Google Scholar]
  31. Munro D. S., Dirmikis S. M., Humphries H., Smith T., Broadhead G. D. The role of thyroid stimulating immunoglobulins of Graves's disease in neonatal thyrotoxicosis. Br J Obstet Gynaecol. 1978 Nov;85(11):837–843. doi: 10.1111/j.1471-0528.1978.tb15839.x. [DOI] [PubMed] [Google Scholar]
  32. O'Donnell J., Trokoudes K., Silverberg J., Row V., Volpé R. Thyrotropin displacement activity of serum immunoglobulins from patients with Graves' disease. J Clin Endocrinol Metab. 1978 May;46(5):770–777. doi: 10.1210/jcem-46-5-770. [DOI] [PubMed] [Google Scholar]
  33. Onaya T., Kotani M., Yamada T., Ochi Y. New in vitro tests to detect the thyroid stimulator in sera from hyperthyroid patients by measuring colloid droplet formation and cyclic AMP in human thyroid slices. J Clin Endocrinol Metab. 1973 May;36(5):859–866. doi: 10.1210/jcem-36-5-859. [DOI] [PubMed] [Google Scholar]
  34. Planells R., Fayet G., Lissitzky S., Hennen G., Closset J. Bioassay of thyrotropin using isolated porcine thyroid cells. FEBS Lett. 1975 Apr 15;53(1):87–91. doi: 10.1016/0014-5793(75)80689-2. [DOI] [PubMed] [Google Scholar]
  35. Rapoport B., Adams R. J. Bioassay of TSH using dog thyroid cells in monolayer culture. Metabolism. 1978 Dec;27(12):1732–1742. doi: 10.1016/0026-0495(78)90259-7. [DOI] [PubMed] [Google Scholar]
  36. Rapoport B., Greenspan F. S., Filetti S., Pepitone M. Clinical experience with a human thyroid cell bioassay for thyroid-stimulating immunoglobulin. J Clin Endocrinol Metab. 1984 Feb;58(2):332–338. doi: 10.1210/jcem-58-2-332. [DOI] [PubMed] [Google Scholar]
  37. Rapoport B., Takai N. A., Filetti S. Evidence for species specificity in the interaction between thyrotropin and thyroid-stimulating immunoglobulin and their receptor in thyroid tissue. J Clin Endocrinol Metab. 1982 May;54(5):1059–1062. doi: 10.1210/jcem-54-5-1059. [DOI] [PubMed] [Google Scholar]
  38. Rickards C., Buckland P., Smith B. R., Hall R. The interaction of Graves' IgG with the thyrotrophin receptor. FEBS Lett. 1981 May 5;127(1):17–21. doi: 10.1016/0014-5793(81)80330-4. [DOI] [PubMed] [Google Scholar]
  39. Schleusener H., Finke R., Kotulla P., Wenzel K. W., Meinhold H., Roedler H. D. Determination of thyroid stimulating immunoglobulins (TSI) during the course of Graves' disease. A reliable indicator for remission and persistence of this disease? J Endocrinol Invest. 1978 Apr;1(2):155–161. doi: 10.1007/BF03350364. [DOI] [PubMed] [Google Scholar]
  40. Shewring G., Smith B. R. An improved radioreceptor assay for TSH receptor antibodies. Clin Endocrinol (Oxf) 1982 Oct;17(4):409–417. doi: 10.1111/j.1365-2265.1982.tb01607.x. [DOI] [PubMed] [Google Scholar]
  41. Smith B. R., Dorrington K. J., Munro D. S. The thyroid-stimulating properties of long-acting thyroid stimulator gamma G-globulin subunits. Biochim Biophys Acta. 1969 Nov 18;192(2):277–285. doi: 10.1016/0304-4165(69)90366-3. [DOI] [PubMed] [Google Scholar]
  42. Smith B. R., Hall R. Thyroid-stimulating immunoglobulins in Graves' disease. Lancet. 1974 Aug 24;2(7878):427–431. doi: 10.1016/s0140-6736(74)91815-7. [DOI] [PubMed] [Google Scholar]
  43. Smyth P. P., Neylan D., O'Donovan D. K. Association of thyroid-stimulating immunoglobulins and thyrotropin-releasing hormone responsiveness in women with euthyroid goiter. J Clin Endocrinol Metab. 1983 Nov;57(5):1001–1006. doi: 10.1210/jcem-57-5-1001. [DOI] [PubMed] [Google Scholar]
  44. Solomon D. H., Chopra I. J., Chopra U., Smith F. J. Identification of subgroups of euthyroid graves's ophthalmopathy. N Engl J Med. 1977 Jan 27;296(4):181–186. doi: 10.1056/NEJM197701272960401. [DOI] [PubMed] [Google Scholar]
  45. Strakosch C. R., Wenzel B. E., Row V. V., Volpé R. Immunology of autoimmune thyroid diseases. N Engl J Med. 1982 Dec 9;307(24):1499–1507. doi: 10.1056/NEJM198212093072407. [DOI] [PubMed] [Google Scholar]
  46. Sugenoya A., Kidd A., Row V. V., Volpé R. Correlation between thyrotropin-displacing activity and human thyroid-stimulating activity by immunoglobulins from patients with Graves' disease and other thyroid disorders. J Clin Endocrinol Metab. 1979 Mar;48(3):398–402. doi: 10.1210/jcem-48-3-398. [DOI] [PubMed] [Google Scholar]
  47. Teng C. S., Smith B. R., Clayton B., Evered D. C., Clark F., Hall R. Thyroid-stimulating immunoglobulins in ophthalmic Graves' disease. Clin Endocrinol (Oxf) 1977 Mar;6(3):207–211. doi: 10.1111/j.1365-2265.1977.tb03316.x. [DOI] [PubMed] [Google Scholar]
  48. Teng C. S., Tong T. C., Hutchison J. H., Yeung R. T. Thyroid-stimulating immunoglobulins in neonatal Graves's disease. Arch Dis Child. 1980 Nov;55(11):894–895. doi: 10.1136/adc.55.11.894. [DOI] [PMC free article] [PubMed] [Google Scholar]
  49. Teng C. S., Yeung R. T. Changes in thyroid-stimulating antibody activity in Graves' disease treated with antithyroid drug and its relationship to relapse: a prospective study. J Clin Endocrinol Metab. 1980 Jan;50(1):144–147. doi: 10.1210/jcem-50-1-144. [DOI] [PubMed] [Google Scholar]
  50. Vitti P., Rotella C. M., Valente W. A., Cohen J., Aloj S. M., Laccetti P., Ambesi-Impiombato F. S., Grollman E. F., Pinchera A., Toccafondi R. Characterization of the optimal stimulatory effects of graves' monoclonal and serum immunoglobulin G on adenosine 3',5'-monophosphate production in fRTL-5 thyroid cells: a potential clinical assay. J Clin Endocrinol Metab. 1983 Oct;57(4):782–791. doi: 10.1210/jcem-57-4-782. [DOI] [PubMed] [Google Scholar]
  51. Vitti P., Valente W. A., Ambesi-Impiombato F. S., Fenzi G. F., Pinchera A., Kohn L. D. Graves' IgG stimulation of continuously cultured rat thyroid cells: a sensitive and potentially useful clinical assay. J Endocrinol Invest. 1982 May-Jun;5(3):179–182. doi: 10.1007/BF03349476. [DOI] [PubMed] [Google Scholar]
  52. Volpé R., Ehrlich R., Steiner G., Row V. V. Graves' disease in pregnancy years after hypothyroidism with recurrent passive-transfer neonatal Graves' disease in offspring. Therapeutic considerations. Am J Med. 1984 Sep;77(3):572–578. doi: 10.1016/0002-9343(84)90125-6. [DOI] [PubMed] [Google Scholar]
  53. Wall J. R., Manwar G. L., Greenwood D. M., Walters B. A. The in vitro suppression of lectin induced 3H-thymidine incorporation into DNA of peripheral blood lymphocytes after the addition of propylthiouracil. J Clin Endocrinol Metab. 1976 Dec;43(6):1406–1409. doi: 10.1210/jcem-43-6-1406. [DOI] [PubMed] [Google Scholar]
  54. Wall J. R., Strakosch C. R., Bandy P., Bayly R. Nature of thyrotropin displacement activity in subacute thyroiditis. J Clin Endocrinol Metab. 1982 Feb;54(2):349–353. doi: 10.1210/jcem-54-2-349. [DOI] [PubMed] [Google Scholar]
  55. Weetman A. P., Holt M. E., Campbell A. K., Hall R., McGregor A. M. Methimazole and generation of oxygen radicals by monocytes: potential role in immunosuppression. Br Med J (Clin Res Ed) 1984 Feb 18;288(6416):518–520. doi: 10.1136/bmj.288.6416.518. [DOI] [PMC free article] [PubMed] [Google Scholar]
  56. Weetman A. P., McGregor A. M. Autoimmune thyroid disease: developments in our understanding. Endocr Rev. 1984 Spring;5(2):309–355. doi: 10.1210/edrv-5-2-309. [DOI] [PubMed] [Google Scholar]
  57. Zakarija M., McKenzie J. M., Banovac K. Clinical significance of assay of thyroid-stimulating antibody in Graves' disease. Ann Intern Med. 1980 Jul;93(1):28–32. doi: 10.7326/0003-4819-93-1-28. [DOI] [PubMed] [Google Scholar]
  58. Zakarija M., McKenzie J. M., Munro D. S. Immunoglobulin G inhibitor of thyroid-stimulating antibody is a cause of delay in the onset of neonatal Graves' disease. J Clin Invest. 1983 Oct;72(4):1352–1356. doi: 10.1172/JCI111091. [DOI] [PMC free article] [PubMed] [Google Scholar]
  59. Zakarija M., McKenzie J. M. Pregnancy-associated changes in the thyroid-stimulating antibody of Graves' disease and the relationship to neonatal hyperthyroidism. J Clin Endocrinol Metab. 1983 Nov;57(5):1036–1040. doi: 10.1210/jcem-57-5-1036. [DOI] [PubMed] [Google Scholar]
  60. van der Gaag R. D., Drexhage H. A., Dussault J. H. Role of maternal immunoglobulins blocking TSH-induced thyroid growth in sporadic forms of congenital hypothyroidism. Lancet. 1985 Feb 2;1(8423):246–250. doi: 10.1016/s0140-6736(85)91028-1. [DOI] [PubMed] [Google Scholar]

Articles from CMAJ: Canadian Medical Association Journal are provided here courtesy of Canadian Medical Association

RESOURCES